Fitbit devices could help predict the flare-ups of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, according to a new study published in the Journal of Crohn's and Colitis. The year-long study, which was recently presented at Digestive Disease Week, was conducted by the University of Chicago.Impact of IBD Flare-UpsEven when managed well, IBD can flare up or cause symptoms unexpectedly, which may be triggered by diet, stress, and physical activity (or lack
Read More
Altoida Raises $6.3M for Early Detection of Alzheimer’s Using AI & Augmented Reality
Altoida Inc., a digital health company using digital
biomarkers to drive better clinical outcomes for brain diseases has raised
$6.3M in Series A funding led by M Ventures, the corporate venture capital arm
of the science and technology company Merck KGaA, Darmstadt, Germany. The round
also includes participation from Grey Sky Venture Partners, VI Partners AG,
Alpana Ventures, and FYRFLY Venture Partners.
Taking Aim at the Alzheimer’s Disease Epidemic
The number of people living with
Read More
Canadian Government Awards $49M Grant to Establish Canada-wide AI Health Data Platform
The government of Canada has announced an investment grant of up to $49 million in the Digital Health and Discovery Platform (DHDP), a network of partners that seeks to establish a cutting-edge Canada-wide health data platform. Through this new platform, researchers and doctors will work to accelerate the development of new and personalized treatments to help to find cures for diseases that affect Canadians. While the platform will initially focus on cancer, the plan is to expand to other areas
Read More
FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
Sonde Health Nabs $16M to Commercialize Vocal Biomarker Device to Diagnose Diseases
Sonde Health, a Boston-based digital medicine company developing a vocal biomarker device to transform the way we monitor and diagnose our mental and physical health has raised $16 million in Series A funding. The round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with participation from MP Healthcare Venture Management, Inc. (the corporate venture capital arm of Mitsubishi Tanabe Pharma Corporation), Neoteny 4, LP, Canepa Healthcare, and founder
Read More
Amazon Alexa Is Now HIPAA-Eligible, What’s Next for Healthcare?
Nathan Treloar, President & COO at Orbita, Inc.
Big News, But Just The Beginning
These days, big news stories in healthcare are just as likely to come from large technology companies as from major healthcare institutions. Case in point: In early 2018, Amazon created a huge stir in the industry early by announcing a venture with JPMorgan and Berkshire Hathaway that promised to go after the “hungry
Read More
Mayo Clinic to Develop New Diagnostic Test Using Patients’ Breath to Detect Lung Cancer
Mayo Clinic Laboratories is teaming up with Breath Diagnostics to develop new clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The first collaboration will focus on a diagnostic test that detects lung cancer using patients' exhaled breath. Benefits of BiomarkersBiomarkers are measurable substances that help in predicting the severity of a disease or infection. Examples of a biomarker include an individual's pulse
Read More
4 Pillars of Value for AI in Medical Imaging
At ECR this year, there were over 25 independent software vendors (ISVs), many of them start-ups, showcasing artificial intelligence (AI) solutions for medical imaging within a dedicated space. Additionally, with established imaging vendors foraying into the AI space, what was once hype is now in the early stages of market maturity, and, it appears, AI within medical imaging is here to stay.
The question has now shifted to what clinical value AI solutions can provide, rather than if AI is
Read More
8 Use Cases for Natural Language Processing (NLP) Technology in Healthcare
A look at natural language processing (NLP) technology's top potential use cases reveals how its destined to disrupt healthcare.It’s no secret that the big data wave had been building in healthcare for some time. What has somewhat remained a bit mysterious, however, is how innovators planned to stave the flood and make use of the sizeable data to help healthcare providers create efficiencies and improve outcomes. According to a recent Chilmark report, natural language processing (NLP) may be the
Read More
1DROP Raises $4.25M to Support Commercialization of Portable Medical Diagnostics Platform
1DROP, a life sciences startup developing and commercializing an easy to use laboratory quality, portable medical diagnostic testing platform has raised $4.25 million in Series A funding led by led by Christian Wildmoser (former partner CVC Capital Partners & Swiss Startup Group Investor). The round also included participation from private investors of the Swiss Startup Group including Dr. Hans-Peter Strebel (owner of On Your Marks), Beat Schillig (IFJ Institute for Young Entrepreneurs) and
Read More